Discovery of N-{5-[3-(3-hydroxypiperidin-1-yl)-1,2,4-oxadiazol-5-yl]-4-methyl-1,3-thiazol-2-yl}acetamide (TASP0415914) as an orally potent phosphoinositide 3-kinase γ inhibitor for the treatment of inflammatory diseases

Class I phosphoinositide 3-kinases (PI3Ks), particularly PI3Kγ, have become attractive drug targets for inflammatory and autoimmune disorders such as rheumatoid arthritis. Herein, we describe the synthesis and the structure–activity relationships (SAR) of a series of 2-amino-5-oxadiazolyl thiazoles,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry 2013-12, Vol.21 (24), p.7578-7583
Hauptverfasser: Oka, Yusuke, Yabuuchi, Tetsuya, Oi, Takahiro, Kuroda, Shoichi, Fujii, Yasuyuki, Ohtake, Hidenori, Inoue, Tomoyuki, Wakahara, Shunichi, Kimura, Kayo, Fujita, Kiyoko, Endo, Mayumi, Taguchi, Kyoko, Sekiguchi, Yoshinori
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!